Coronavirus in China: 'Funding issues won’t stand in the way of medical treatment,' says government

New Delhi: China is planning to spend more money to help prevent and control the rampant spread of Covid-19. According to a report in South China Morning Post, “Ministry of Finance is telling local governments to transfer more funds to rural and poor areas.” Ministry of Finance has said that the funding should mainly be used for treatment, work allowances for medical staff, vaccinations and improving medical treatment capabilities. China stopped reporting data on COVID-19 deaths and infections after abruptly lifting anti-virus controls in early December despite a surge in infections that began in October and has filled hospitals with feverish, wheezing patients. Hospitals in Beijing across the country have been overwhelmed with patients, and funeral homes and crematoriums have struggled to handle the dead. The World Health Organization and other governments appealed for information after reports by city and provincial governments suggested as many as hundreds of millions of people in China might have contracted the virus. Infection numbers now appear to be falling based on a decline in the number of patients visiting fever clinics, said a National Health Commission official, Jiao Yahui. The daily number of people going to those clinics peaked at 2.9 million on December 23 and had fallen by 83% to to 477,000 on Thursday, according to Jiao. “These data show the national emergency peak has passed,” Jiao said at a news conference. Whether China truly has passed a COVID-19 peak is hard to assess, said Dr. Dale Bratzler, chief COVID officer at the University of Oklahoma and head of quality control at the university’s hospital. For nearly three years, China had kept its infection rate and deaths far lower than those of the United States and some other countries at the height of the pandemic with a “zero-COVID” strategy that aimed to isolate every case. That shut down access to some cities, kept millions of people at home and sparked angry protests. Those rules were suddenly eased in early December after some of the largest shows of public dissent against the ruling Communist Party in more than 30 years. That set off new problems in a country that relies on domestically developed vaccines that are less reliable than others used globally, and where older people — those more susceptible to dying from the virus — are less likely to be vaccinated than the general population. The United States, South Korea, Japan and several other countries have imposed virus testing and other controls on people arriving from China. Beijing retaliated on Wednesday by suspending issuance of new visas to travelers from South Korea and Japan. This month, WHO Director-General Tedros Adhanom Ghebreyesus said agency officials met with Chinese officials to underline the importance of sharing more details about COVID-19 issues, including hospitalization rates and genetic sequences. Read all the Latest News , Trending News ,  Cricket News , Bollywood News , India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.